BRONTE, Giuseppe
BRONTE, Giuseppe
Medicina di Precisione in Area Medica, Chirurgica e Critica
A headlight on liquid biopsies: a challenging tool for breast cancer management
2016-01-01 Massihnia, D.; Perez, A.; Bazan, V.; Bronte, G.; Castiglia, M.; Fanale, D.; Barraco, N.; Cangemi, A.; Di Piazza, F.; Calò, V.; Rizzo, S.; Cicero, G.; Pantuso, G.; Russo, A.
A literature-based meta-analysis of the comparison between Gemcitabine-based combination and monochemotherapy for the treatment of advanced non-small cell lung cancer in elderly patients
2009-01-01 Rizzo, S; Bronte, G; Federico, M; Bruno, D; Piazza, D; Grassi, N; Pantuso, G; Frazzetta, M; Russo, A
A non common BRAF mutation c1799-1801 delTGA identified in sporadic colon rectal cancer of sicilian patients
2010-11-01 Bruno, L; Calò, V; Rizzo, S; Bronte, G; Marganese, N; Cimino, S; Napoli, L; Damiani, GB; Di Gaudio, F; La Paglia, L; Di Piazza, F; Miraglia, MC; Bazan, V; Russo, A.
A Phase II Trial of Fixed-Dose Rate Gemcitabine plus Capecitabine in Metastatic/Advanced Biliary Tract Cancer Patients
2012-01-01 Santini, D; Virzi, V; Vasile, E; Vincenzi, B; Catalano, V; Graziano, F; Masi, G; Bronte, G; Russo, A; Falcone, A; Tonini, G
Adjuvant Chemoradiation Therapy in Gastric Cancer: Critically Reviewing the Past and Visualizing the Next Step Forward
2015-01-01 Papadimitriou, K.; Antoniou, G.; Rolfo, C.; Russo, A.; Bronte, G.; Vassiliou, V.; Papamichael, D.; Peeters, M.; Kountourakis, P.
ALK and crizotinib: After the honeymoon...what else? Resistance mechanisms and new therapies to overcome it
2014-01-01 Rolfo, Christian*; Passiglia, Francesco; Castiglia, Marta; Raez, Luis E.; Germonpre, Paul; Gil-Bazo, Ignacio; Zwaenepoel, Karen; De Wilde, Annemieke; Bronte, Giuseppe; Russo, Antonio; Van Meerbeeck, Jan P.; Van Schil, Paul; Pauwels, Patrick
An all-oral combination regimen of vinorelbine and capecitabine for elderly patients with metastatic breast cancer
2006-01-01 CARRECA I; BRONTE G; BURGIO M; CARRECA A; PIAZZA D; RIZZO S; RUSSO S
Analysis of germline gene copy number variants of patients with sporadic pancreatic adenocarcinoma reveals specific variations
2009-01-01 Fanale, D; Corsini, LR; D'Andrea, A; Terrasi, M; La Paglia, L; Amodeo, V; Bronte, G; Rizzo, S; Insalaco, L; Perez, M; Cimino, S; Bruno, L; Calò, V; Agnese, V; Symonds, CE; Federico, M; Grassi, N; Pantuso, G; Frazzetta, M; Bazan, V; Calvo, EL; Iovanna, JL; Russo, A
Analysis of Germline Gene Copy Number Variants of Patients with Sporadic Pancreatic Adenocarcinoma Reveals Specific Variations
2013-01-01 Fanale, D; Iovanna, JL; Calvo, EL; Berthezene, P; Belleau, P; Dagorn, JC; Ancona, C; Catania, G; D'Alia, P; Galvano, A; Gulotta, E; Lo Dico, S; Passiglia, F; Bronte, G; Midiri, M; Lo Re, G; Cicero, G; Bazan, V; Russo, A.
Analysis of tissue and circulating microRNA expression during metaplastic transformation of the esophagus
2016-01-01 Cabibi, D.; Caruso, S.; Bazan, V.; Castiglia, M.; Bronte, G.; Ingrao, S.; Fanale, D.; Cangemi, A.; Calò, V.; Listì, A.; Incorvaia, L.; Galvano, A.; Pantuso, G.; Fiorentino, E.; Castorina, S.; Russo, A.
Anti-angiogenic drugs for second-line treatment of NSCLC patients: Just new pawns on the chessboard?
2016-01-01 Bronte, Giuseppe; Passiglia, Francesco; Galvano, Antonio; Russo, Antonio*
Anti-endothelin drugs in solid tumors
2010-01-01 Russo, A; Bronte, G; Rizzo, S; Fanale, D; Di Gaudio, F; Gebbia, N; Bazan, V.
Antiemetic prophylaxis containing Palonosetron (P) alone or in combination with Aprepitant (A) in the treatment of advanced soft tissue sarcoma (STS) patients with epirubicin and ifosfamide
2009-01-01 Bronte, G; Incorvaia, L; Cuttone, F; Maltese, G; Scibilia, C; Bartolotta, S; Albanese, V; Rizzo, S; Federico, M; Fiorentino, FP; Grassi, N; Pantuso, G; Frazzetta, M; Russo, A; Badalamenti, G
Apoptosis in Thyroid Autoimunity.
2007-01-01 Giordano C; Richiusa P; Bronte V; Criscimanna A
Are erlotinib and gefitinib interchangeable, opposite or complementary for non-small cell lung cancer treatment? Biological, pharmacological and clinical aspects
2014-01-01 Bronte, G; Rolfo, C; Giovannetti, E; Cicero, G; Pauwels, P; Passiglia, F; Castiglia, M; Rizzo, S; Lo Vullo, F; Fiorentino, E; Van Meerbeeck, J; Russo, A
Beyond evidence-based data: Scientific rationale and tumor behavior to drive sequential and personalized therapeutic strategies for the treatment of metastatic renal cell carcinoma
2016-01-01 Incorvaia, L.; Bronte, G.; Bazan, V.; Badalamenti, G.; Rizzo, S.; Pantuso, G.; Natoli, C.; Russo, A
BIBF 1120/nintedanib: a new triple angiokinase inhibitor-directed therapy in patients with non-small cell lung cancer
2013-01-01 Rolfo, C; Raez, L; Bronte, G; Santos, E; Papadimitriou, K; Buffoni, L; Meerbeeck, J; Russo, A
Bortezomib: a new pro-apoptotic agent in cancer treatment.
2010-01-01 Russo, A; Bronte, G; Fulfaro, F; Cicero, G; Adamo, V; Gebbia, N; Rizzo, S
BRCA1 and BRCA2 germline mutations in sicilian breast and/or ovarian cancer families and their association with familial profiles
2009-01-01 Calo, V; Bruno, L; La Paglia, L; Schirò, V; Agnese, V; Calcara, D; Cimino, S; Fanale, D; D'andrea, A; Corsini, LR; Amodeo, V; Rizzo, S; Terrasi, M; Bronte, G; Bruno, D; Piazza, D; Fiorentino, FP; Grassi, N; Pantuso, G; Frazzetta, M; Symonds, CE; Federico, M; Bazan, V; Russo, A
BRCA1 and BRCA2 variants of uncertain clinical significance and their implications for genetic counseling
2009-01-01 Bruno, L; Calò, V; Schirò, V; La Paglia, L; Agnese, V; Calcara, D; Cimino, S; Fanale, D; D'Andrea, A; Corsini, LR; Amodeo, V; Rizzo, S; Terrasi, M; Bronte, G; Bruno, D; Piazza, D; Symonds, ES; Federico, M; Fiorentino, FP; Grassi, N; Pantuso, G; Frazzetta, M; Bazan, V; Russo, A